# COVID-19 With Convalescent Plasma

> **NCT04616976** · — · COMPLETED · sponsor: **Southeast University, China** · enrollment: 78 (actual)

## Conditions studied

- COVID-19 Convalescent Plasma Treatment

## Interventions

- **BIOLOGICAL:** convalescent plasma

## Key facts

- **NCT ID:** NCT04616976
- **Lead sponsor:** Southeast University, China
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2020-02-29
- **Final completion:** 2020-11-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04616976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04616976, "COVID-19 With Convalescent Plasma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04616976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*